Nova Leap HealthNVLPF 50 PB Ratio is 1.13 as of Jun. 25, 2026, which is 41% below its 10-year median of 1.90. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.19 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Nova Leap Health ranks better than 65.3% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), Nova Leap Health's share price is $0.24648. Nova Leap Health's Book Value per Share for the quarter that ended in Mar. 2026 was $0.22. Hence, Nova Leap Health's PB Ratio of today is 1.13.
Warning Sign:
Nova Leap Health Corp stock PB Ratio (=1.37) is close to 3-year high of 1.4.
The historical rank and industry rank for Nova Leap Health's PB Ratio or its related term are showing as below:
NVLPF'
s PB Ratio Range Over the Past 10 Years
Min: 0.46 Med: 1.9 Max: 11.54
Current: 1.37
During the past 10 years, Nova Leap Health's highest PB Ratio was 11.54. The lowest was 0.46. And the median was 1.90.
NVLPF's PB Ratio is ranked better than 65.3% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs NVLPF: 1.37
During the past 12 months, Nova Leap Health's average Book Value Per Share Growth Rate was 0.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 0.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.50% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Nova Leap Health was 120.50% per year. The lowest was 0.00% per year. And the median was 25.10% per year.
Back to Basics: PB Ratio
Nova Leap Health (OTCPK:NVLPF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Nova Leap Health PB Ratio Related Terms
Nova Leap Health PB Ratio Historical Data
* Premium members only.
The historical data trend for Nova Leap Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nova Leap Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Leap Health PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Nova Leap Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Nova Leap Health (NVLPF) has a PB Ratio of 1.13 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nova Leap Health and its competitors. This is 41% below median its historical median of 1.90. Over the past decade, Nova Leap Health's PB Ratio has ranged from 0.46 to 11.54. According to the industry distribution chart, Nova Leap Health ranks #212 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 34.7%.
Is Nova Leap Health's PB Ratio too high?
Nova Leap Health's current PB Ratio of 1.13 is 41% below median its 10-year median of 1.90. Over the past 10 years, this metric has ranged from a low of 0.46 to a high of 11.54. The Healthcare Providers & Services industry median PB Ratio is 1.98. Nova Leap Health's value of 1.13 is 42.9% below this industry median. Based on the distribution chart, Nova Leap Health ranks #212 out of 611 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #212 out of 611 companies for PB Ratio. This puts Nova Leap Health in the upper half of its industry. The industry median PB Ratio is 1.98. Nova Leap Health's value of 1.13 is 42.9% below this benchmark. Historically, Nova Leap Health's own PB Ratio has ranged from 0.46 to 11.54 over the past decade. While the company's 10-year median is 1.90 vs. the industry median of 1.98, Nova Leap Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Leap Health's current PB Ratio of 1.13 is 42.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current PB Ratio is 1.13, which is 41% below median its own 10-year median of 1.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.19, compared to a current price of $0.25 — trading 29.7% above its estimated fair value. The current PB Ratio is 1.13, which is 41% below median its 10-year median of 1.90 and 42.9% below the Healthcare Providers & Services industry median of 1.98. Nova Leap Health's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current PB Ratio is 1.13 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova Leap Health (NVLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued.
The current stock price of $0.25 is trading 29.7% above its estimated GF Value™ of $0.19.
GuruFocus considers Nova Leap Health to be Modestly Overvalued.
Key valuation signals for NVLPF:
PB Ratio: 1.13 (41% below median its 10-year median of 1.90)
GF Value™: $0.19 vs. price of $0.25 (29.7% above fair value)
Industry Position: 42.9% below the Healthcare Providers & Services median (#212 of 611)
No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score
Get the complete analysis for NVLPF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVLPF has been successfully added to your 
